Aetna, the third largest health plan in the United States, now provides coverage of NxGen's services via their published Clinical Policy Bulletin (CPB) following a thorough review of the Company's products. In addition, many physicians supported the inclusion of NxGen MDx in the network due to their stated belief that NxGen MDx's suite of services are best-in-class tools and aid in informed decision-making. According to Dr. Mark Perloe, Medical Director at Georgia Reproductive Specialists in Atlanta, "Having NxGen MDx in the Aetna network allows me the flexibility to use the testing services that I believe are in my patients' best interest."
"Patients will now have in-network access to selected tests, streamlining the billing process and potentially lowering out of pocket costs depending on their benefit plan design" said Kristin Sherman, CFO of NxGen MDx. "This also removes a barrier for many health care professionals who have wanted to use our testing in the past."
About NxGen MDx
NxGen MDx LLC is a leading women's health company delivering highly accurate and precise genetic screening to detect genetic diseases or abnormalities to help guide family planning decisions for couples and their health care providers. Unlike other laboratories, NxGen MDx's technology examines the entire gene rather than parts of the gene, giving families a comprehensive assessment of their true risk. NxGen MDx is located in Grand Rapids, Michigan. To learn more, visit the company's website at www.nxgenmdx.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nxgen-mdx-issues-revised-announcement-regarding-national-aetna-contract-300413139.html
SOURCE NxGen MDx